Chaim Lebovits - Net Worth and Insider Trading
Chaim Lebovits Net Worth
The estimated net worth of Chaim Lebovits is at least $870,571 dollars as of 2024-09-13. Chaim Lebovits is the President & CEO of Brainstorm Cell Therapeutics Inc and owns about 3,165,712 shares of Brainstorm Cell Therapeutics Inc (BCLI) stock worth over $870,571. Details can be seen in Chaim Lebovits's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Chaim Lebovits has not made any transactions after 2024-05-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Chaim Lebovits
Chaim Lebovits Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Chaim Lebovits owns 1 companies in total, including Brainstorm Cell Therapeutics Inc (BCLI) .
Click here to see the complete history of Chaim Lebovits’s form 4 insider trades.
Insider Ownership Summary of Chaim Lebovits
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCLI | Brainstorm Cell Therapeutics Inc | 2024-05-28 | Chief Executive Officer |
Chaim Lebovits Latest Holdings Summary
Chaim Lebovits currently owns a total of 1 stock. Chaim Lebovits owns 3,165,712 shares of Brainstorm Cell Therapeutics Inc (BCLI) as of May 28, 2024, with a value of $870,571.
Latest Holdings of Chaim Lebovits
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BCLI | Brainstorm Cell Therapeutics Inc | 2024-05-28 | 3,165,712 | 0.28 | 870,571 |
Holding Weightings of Chaim Lebovits
Chaim Lebovits Form 4 Trading Tracker
According to the SEC Form 4 filings, Chaim Lebovits has made a total of 7 transactions in Brainstorm Cell Therapeutics Inc (BCLI) over the past 5 years, including 7 buys and 0 sells. The most-recent trade in Brainstorm Cell Therapeutics Inc is the acquisition of 15,000 shares on May 28, 2024, which cost Chaim Lebovits around $7,800.
Insider Trading History of Chaim Lebovits
- 1
Chaim Lebovits Trading Performance
GuruFocus tracks the stock performance after each of Chaim Lebovits's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Chaim Lebovits is -32.89%. GuruFocus also compares Chaim Lebovits's trading performance to market benchmark return within the same time period. The performance of stocks bought by Chaim Lebovits within 3 months outperforms 0 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Chaim Lebovits's insider trading performs compared to the benchmark.
Performance of Chaim Lebovits
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -9.7 |  | | | | |
| Relative Return to S&P 500(%) | -13.84 | | | | | |
Chaim Lebovits Ownership Network
Chaim Lebovits Owned Company Details
What does Brainstorm Cell Therapeutics Inc do?
Who are the key executives at Brainstorm Cell Therapeutics Inc?
Chaim Lebovits is the Chief Executive Officer of Brainstorm Cell Therapeutics Inc. Other key executives at Brainstorm Cell Therapeutics Inc include EVP & Head Global Clin Research Stacy Lindborg , Chief Medical Officer Kirk Taylor , and See Remarks Alla Patlis .
Brainstorm Cell Therapeutics Inc (BCLI) Insider Trades Summary
Over the past 18 months, Chaim Lebovits made 7 insider transaction in Brainstorm Cell Therapeutics Inc (BCLI) with a net purchase of 566,372. Other recent insider transactions involving Brainstorm Cell Therapeutics Inc (BCLI) include a net sale of 63,000 shares made by , a net purchase of 11,500 shares made by Stacy Lindborg ,
In summary, during the past 3 months, insiders sold 63,000 shares of Brainstorm Cell Therapeutics Inc (BCLI) in total and bought 0 shares, with a net sale of 63,000 shares. During the past 18 months, 63,000 shares of Brainstorm Cell Therapeutics Inc (BCLI) were sold and 577,872 shares were bought by its insiders, resulting in a net purchase of 514,872 shares.
Brainstorm Cell Therapeutics Inc (BCLI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Brainstorm Cell Therapeutics Inc Insider Transactions
Chaim Lebovits Mailing Address
Above is the net worth, insider trading, and ownership report for Chaim Lebovits. You might contact Chaim Lebovits via mailing address: 110 East 59th Street, New York Ny 10019.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
